A nurse is caring for a client who has heart failure and is taking hydrochlorothiazide. The nurse should monitor the client for which of the following manifestations as an adverse effect of the medication?
Hypocalcemia
Hypernatremia
Hypokalemia
Hypermagnesemia
The Correct Answer is C
A. Hypocalcemia: Hydrochlorothiazide is not typically associated with lowering calcium levels. Hypocalcemia is not a common adverse effect of this medication.
B. Hypernatremia: Hydrochlorothiazide is a diuretic that increases urination, leading to the loss of water and sodium. While it can cause sodium depletion, it's less likely to result in hypernatremia, which refers to high sodium levels in the blood.
C. Hypokalemia: Hydrochlorothiazide is a thiazide diuretic that can increase the excretion of potassium in the urine. Hypokalemia (low potassium levels) is a known adverse effect of this medication due to its action on the kidneys leading to potassium loss.
D. Hypermagnesemia: Hydrochlorothiazide does not typically cause an increase in magnesium levels. It's more likely to cause magnesium loss through increased urination, potentially leading to hypomagnesemia (low magnesium levels) rather than hypermagnesemia.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
A. Transdermal: Epoetin alfa is not available for transdermal administration. It's a medication typically administered by injection.
B. Oral: Epoetin alfa is not orally active and is not available in oral form. The oral route is not suitable for this medication due to its large molecular size and degradation in the digestive system.
C. Intravenous (IV): This is the correct route for administering epoetin alfa. It is usually given as an intravenous injection in clinical settings.
D. Inhalation: Epoetin alfa is not formulated for inhalation. It is not administered through the respiratory system but rather through injection, most commonly intravenously.
Correct Answer is D
Explanation
A. Insulin glargine:
Insulin glargine is a long-acting insulin used to control blood sugar levels in people with diabetes. However, it is typically not the first-line choice for a client with a new diagnosis of metabolic syndrome and an HbA1c of 6.
B. Regular insulin:
Regular insulin is a short-acting insulin used to control blood sugar levels, but it is not typically the first choice for initial management of metabolic syndrome. It may be considered in certain situations, but other options are often explored first.
C. Exenatide:
Exenatide is a medication that belongs to the class of incretin mimetics and is used to improve blood sugar control. However, it may not be the first choice for initial treatment.
D. Metformin:
This is the correct answer. Metformin is a first-line medication for the treatment of type 2 diabetes and is commonly used to manage metabolic syndrome. It helps improve insulin sensitivity and reduce glucose production by the liver.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.